Contract Research Organization (CRO) Market 2019 Global Forecasts in New Research Reports
DALLAS, January 7, 2015 /PRNewswire/ --
ReportsnReports.com adds "Global CRO Market 2015-2019" research report of 75 pages to the healthcare and pharmaceuticals industry intelligence collection of its online business research and data library.
Following companies of Global CRO Market are recognized as the key players in this research with 2019 forecasts: Covance Inc., PAREXEL International Corp., PRA Health Sciences Inc. and Quintiles Transnational Holdings Inc. Other Prominent Vendors in the market are: Charles River Laboratories, Chiltern, EPS, Icon, INC Research, Inventiv Health, QPS, Ricerca Biosciences, SynteractHCR, WIL Research and WuXi AppTec. Complete report is available at http://www.reportsnreports.com/reports/322423-global-cro-market-2015-2019.html .
Commenting on this contract research organization (CRO) market report, an analyst from the report publishing team said: "Increased R&D by biopharmaceutical vendors is one of the major trends emerging in the market. Customers are increasingly opting for biopharmaceutical drugs rather than chemical pharmaceuticals drugs for the treatment of some diseases such as diabetes, cancer, and genetic diseases because biopharmaceutical drugs offer several advantages."
According to this worldwide CRO market (contract research organization) research, increased outsourcing of R&D activities by global pharmaceutical and biopharmaceutical vendors is one of the main drivers of the market. Several tier I and tier II pharmaceutical and biopharmaceutical vendors are outsourcing R&D and clinical trial activities to CROs to reduce their expenditure on R&D activities. Further, the report states that the shortage of experienced personnel to conduct various activities in CROs is one of the main challenges in the market. Moreover, many CROs do not have sufficient personnel to fulfill the R&D demands of several vendors
The CRO market can be divided into two segments: Early-stage Development Services and Late-stage Development Services. To calculate the market size, the report considers the revenue generated from the sales of outsourcing of R&D services to CROs by global pharmaceutical and biopharmaceutical vendors. This research forecasts the Global CRO market to grow at a CAGR of 9.83% over the period 2014-2019. Order a copy of this research at http://www.reportsnreports.com/Purchase.aspx?name=322423 .
Organizations that support outsourced research services for the Pharmaceutical, Biotechnology, and Medical Devices industries are called CROs. The nature of engagement of outsourced services is generally on contractual basis. This helps the vendors to control their R&D expenditure and concentrate on their core skills. CROs help vendors expand their capacities from clinical trials to healthcare regulatory submissions, biostatistics, and data management work. Furthermore, CROs have also started offering services at all phases (pre-clinical, phase I, phases II & IIIa, phases IIIb & IV, labs, and others) of drug development and discovery. CROs have built their capabilities from the earliest to the latest stages of drug development with emphasis on partnership, collaboration, and fee for service models.
The Global CRO Market 2015-2019 research report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global CRO market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
On similar lines, the Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 6th Edition report by Kalorama Information is an authoritative resource that defines the market opportunity for companies assisting in the beginning phase of the drug development process. It provides an in depth look into the trends that have shaped the drug discovery outsourcing market today, and details the current and future global market. As part of its coverage, the report provides markets and forecasts for the following segments.
- Chemistry Services Market: Building Blocks, Compound
- Synthesis, Libraries, Process Research, and Other Services,
- Biology Market Revenue by Protein Expression, Structural
- Analysis, Target Validation, Pathways Analysis, and Other Service
- Screening Services Market: Assay Development, Primary
- Screening, Secondary Screening
- Lead Optimization Services Market: Early ADMET/Tox, Create Analogues, Computational Support, and Other Services
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a target protein or nucleic acid in a way that is useful for treatment of disease. The process by which molecules are identified for their therapeutic value involves synthesis and analysis of many derivatives of the original leads. There are several steps in the drug discovery process including hit confirmation, lead generation, lead optimization, and other studies. Drug discovery is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will actually yield products that achieve regulatory approval by the Food & Drug Administration (FDA).
Companies profiled in this research include Albany Molecular Research, Inc., Aptuit, LLC, Argenta Discovery, Ltd., Asclepia MedChem Solutions, Asinex Ltd., AsisChem, Inc., Axxam SpA, BioDuro, BioFocus DPI, Caliper Life Sciences, Charles River Laboratories, Inc., ChemBridge Corp., Chemical Diversity Inc., Covance, Inc., CreaGen Biosciences, Inc., Crown Bioscience, Cyprotex PLC, Domainex, Emerald Biostructures, Enamine Ltd., Evotec AG, Exelgen Discovery, GVK Biosciences Private Limited, GenScript USA Inc., Graffinity Pharmaceuticals GmbH, Hutchison MediPharma Ltd., Jubilant Biosys Ltd, Nanosyn, Inc., Pharmaron Inc., Ricerca Biosciences, LLC, Scynexis, Inc., Selcia Limited, Selvita S.A., Shanghai ChemPartner Co., Ltd., Shanghai Medicilon Inc., Sundia Meditech Company, Ltd., Sygnature Discovery Limited, TCG Lifesciences Limited, Viva Biotech, Ltd and WuXI AppTec Co. Ltd. Order a copy of this research at http://www.reportsnreports.com/Purchase.aspx?name=163649 .
Explore more reports on pharmaceuticals market and newly published research on the overall healthcare industry http://www.reportsnreports.com/market-research/healthcare/ .
About Us:
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. We provide reports by 100+ publishers on a range of categories and industries.
Contact:
Ritesh Tiwari / Priyank Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
Connect with Us:
G+ / Google Plus: https://plus.google.com/u/0/111656568937629536321/posts
Twitter: http://twitter.com/marketsreports
Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689
RSS / Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml
SOURCE ReportsnReports
Share this article